Shifa Biomedical Corporation (Shifa) is a structure-based drug discovery company.  It is a privately held biopharmaceutical company dedicated to the rapid, cost-effective development of drugs for the treatment of cancer and cardiovascular diseases, and the development of vaccine technology.  Incorporated in 2006, Shifa has the expertise essential for the rational design of small molecule drugs and the development of vaccines, including expertise in biochemical, cell-based, and virtual screening, molecular biology, biochemistry, crystallography and biophysical, medicinal, computational and combinatorial chemistry.  Shifa is led by a highly-experienced team of scientists with extensive expertise in early drug discovery